- Inhibítory PCSK9 a postavenie evolokumabu v liečbe pacientov s hyperl…
Number of the records: 1  

Inhibítory PCSK9 a postavenie evolokumabu v liečbe pacientov s hyperlipoproteinémiou

  1. TitleInhibítory PCSK9 a postavenie evolokumabu v liečbe pacientov s hyperlipoproteinémiou = PCSK9 inhibitors and the role of evolocumab in the therapy for patients with hyperlipoproteinemia / Andrej Dukát ... [et al.]
    Another responsib. Dukát, Andrej, 1950- (Author)
    Kriška, Milan, 1940- (Author)
    Sabaka, Peter (Author)
    Gavorník, Peter, 1948-2022 (Author)
    Kužma, Martin (Author)
    Payer, Juraj, 1958- (Author)
    Phys.des.ilustr., tab.
    Par.titlePCSK9 inhibitors and the role of evolocumab in the therapy for patients with hyperlipoproteinemia
    NoteBibliogr. odkazy. Res. angl., slov.
    In Forum diabetologicum. -- ISSN 1805-3807. -- Roč. 7, č. 1 (2018), s. 71-75
    Call numberC 3133
    LanguageSlovak
    CountryCzech Republic
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.